Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atrial natriuretic factor in heart insufficiency].

R Isnard1, M Komajda, A Carayon

  • 1Service de Cardiologie, Hôpital Pitié-Salpêtrière, Paris.

Presse Medicale (Paris, France : 1983)
|September 12, 1992
PubMed
Summary

Atrial natriuretic factor (ANF) is a peptide released by heart cells, rising with heart failure severity. While a good marker, its therapeutic use is limited by short effects and delivery methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studies on the presence of insulin in rat brain.

Neurochemistry international·2010
Same author

Diagnostic and prognostic value of endothelin-1 plasma concentrations in dogs with heart and respiratory disorders.

The Veterinary record·2006
Same author

Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients.

European journal of clinical pharmacology·2004
Same author

Renal and hormonal responses to isotonic saline infusion after 3 days' head-down tilt vs. supine and seated positions.

Acta physiologica Scandinavica·2003
Same author

Bradykinin-induced neuropeptide Y release by human pheochromocytoma tissue.

Neuropeptides·2002
Same author

[Names-Lab : a model for the standardization of biology message exchanges].

Annales de biologie clinique·2002

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Context:

  • Atrial natriuretic factor (ANF) is synthesized by atrial myocytes and has vasodilator/natriuretic properties.
  • In chronic heart failure, ventricular ANF synthesis increases, correlating with filling pressures.
  • Elevated plasma ANF reflects heart failure severity but its role in neuro-hormonal balance is unclear.

Purpose:

  • To evaluate atrial natriuretic factor as a biological marker for heart failure.
  • To discuss the limitations and potential therapeutic applications of ANF.

Summary:

  • Atrial natriuretic factor (ANF) concentration increases with heart failure severity, making it a potential marker.
  • Its biological effects are often attenuated, and therapeutic use requires parenteral administration.
  • Research is ongoing into enzyme inhibitors to enhance ANF's metabolic stability and therapeutic efficacy.

Impact:

  • ANF serves as a valuable indicator of heart failure severity.
  • Current therapeutic applications of ANF are limited.
  • Future research may overcome limitations through metabolic enzyme inhibition.

Related Experiment Videos